These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 238376

  • 1. Dopamine receptors and cholinergic neurons in the rat neostriatum.
    Guyenet PG, Javoy F, Agid Y, Beaujouan JC, Glowinski J.
    Adv Neurol; 1975; 9():43-51. PubMed ID: 238376
    [No Abstract] [Full Text] [Related]

  • 2. Modification of striatal acetylcholine concentration by dopamine receptor agonists and antagonists.
    Sethy VH, VAN Woert MH.
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):13-28. PubMed ID: 4847901
    [No Abstract] [Full Text] [Related]

  • 3. Effects of dopaminergic receptor agonists and antagonists on the activity of the neo-striatal cholinergic system.
    Guyenet PG, Javory AF, Beaujouan JC, Rossier BJ, Glowinski J.
    Brain Res; 1975 Feb 07; 84(2):227-44. PubMed ID: 234276
    [Abstract] [Full Text] [Related]

  • 4. Regulation of striatal acetylcholine concentration by dopamine receptors.
    Sethy VH, Van Woert MH.
    Nature; 1974 Oct 11; 251(5475):529-30. PubMed ID: 4421728
    [No Abstract] [Full Text] [Related]

  • 5. Modulation of acetylcholine in the neostriatum by dopamine and 5-hydroxytryptamine.
    Butcher SH, Cho AK.
    Proc West Pharmacol Soc; 1976 Oct 11; 19():130-5. PubMed ID: 995978
    [No Abstract] [Full Text] [Related]

  • 6. Neurochemical evidence for denervation supersensitivity: the effect of unilateral substantia nigra lesions on apomorphine-induced increases in neostriatal acetylcholine levels.
    Fibiger HC, Grewaal DS.
    Life Sci; 1974 Jul 01; 15(1):57-63. PubMed ID: 4549908
    [No Abstract] [Full Text] [Related]

  • 7. Decrease in rat striatal acetylcholine levels by some direct- and indirect-acting dopaminergic antagonists.
    Consolo S, Ladinsky H, Bianchi S.
    Eur J Pharmacol; 1975 Jul 01; 33(2):345-51. PubMed ID: 1183479
    [Abstract] [Full Text] [Related]

  • 8. Dopaminergic receptor activity in substantia nigra in the mechanisms of autoregulation of striatal dopamine release.
    Groppetti A, Parenti M, Cattabeni F, Maggi A, De Angelis L, Monduzzi M, Racagni G.
    Adv Biochem Psychopharmacol; 1978 Jul 01; 19():363-71. PubMed ID: 696464
    [No Abstract] [Full Text] [Related]

  • 9. Antagonism of N-methyl-D-aspartate-induced transmitter release in the rat striatum by phencyclidine-like drugs and its relationship to turning behavior.
    Snell LD, Johnson KM.
    J Pharmacol Exp Ther; 1985 Oct 01; 235(1):50-7. PubMed ID: 2864436
    [Abstract] [Full Text] [Related]

  • 10. Involvement of brain cholinergic mechanisms in the action of chlorpromazine.
    Trabucchi M, Cheney D, Racagni G, Costa E.
    Nature; 1974 Jun 14; 249(458):664-6. PubMed ID: 4833805
    [No Abstract] [Full Text] [Related]

  • 11. Effects of neuroleptics on the nigroneostriatal and mesocortical dopaminergic systems.
    Glowinski J.
    Res Publ Assoc Res Nerv Ment Dis; 1975 Jun 14; 54():233-46. PubMed ID: 769114
    [No Abstract] [Full Text] [Related]

  • 12. Drug-induced dopaminergic supersensitivity.
    Moore KE, Thornburg JE.
    Adv Neurol; 1975 Jun 14; 9():93-104. PubMed ID: 1146661
    [No Abstract] [Full Text] [Related]

  • 13. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR, Hu XT, Galloway MP, White FJ.
    Synapse; 1989 Jun 14; 4(4):327-46. PubMed ID: 2532422
    [Abstract] [Full Text] [Related]

  • 14. The brain's dopamine receptor: labeling with (3H) dopamine and (3H) haloperidol.
    Snyder SH, Creese I, Burt DR.
    Psychopharmacol Commun; 1975 Jun 14; 1(6):663-73. PubMed ID: 1241457
    [No Abstract] [Full Text] [Related]

  • 15. Induction of depolarization block in midbrain dopamine neurons by repeated administration of haloperidol: analysis using in vivo intracellular recording.
    Grace AA, Bunney BS.
    J Pharmacol Exp Ther; 1986 Sep 14; 238(3):1092-100. PubMed ID: 3746660
    [Abstract] [Full Text] [Related]

  • 16. Effects of morphine and haloperidol on the electrical activity of rat nigrostriatal neurons.
    Iwatsubo K, Clouet DH.
    J Pharmacol Exp Ther; 1977 Aug 14; 202(2):429-36. PubMed ID: 886472
    [Abstract] [Full Text] [Related]

  • 17. Long-term effects of haloperidol, Clozapine, and methadone on rat striatal cholinergic and dopaminergic dynamics.
    Ladinsky H, Consolo S, Samanin R, Algeri S, Ponzio F.
    Adv Biochem Psychopharmacol; 1980 Aug 14; 24():259-65. PubMed ID: 7405665
    [No Abstract] [Full Text] [Related]

  • 18. Relation between rotation in the 6-OHDA lesioned rat and dopamine loss in striatal and substantia nigra subregions.
    Olds ME, Jacques DB, Kopyov O.
    Synapse; 2006 Jun 15; 59(8):532-44. PubMed ID: 16565974
    [Abstract] [Full Text] [Related]

  • 19. Evidence for multiple dopamine receptors involved in the modulation of acetylcholine release in the striatum.
    Hársing LG, Vizi ES.
    Pol J Pharmacol Pharm; 1985 Jun 15; 37(3):383-96. PubMed ID: 2866504
    [Abstract] [Full Text] [Related]

  • 20. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar 15; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.